Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 as an Adjunct Therapy in Pediatric Community-Acquired Pneumonia
NCT07317440Not yet recruiting
- Sponsor
- Tanta University
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of Coenzyme Q10 mucoadhesive tablets in community acquired pneumonia (CAP) (2 arms), sponsored by Tanta University. Primary endpoints: Normalization of respiratory rate at 3 days, Normalization of temperature at 3 days and 8 more. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
Coenzyme Q10 mucoadhesive tablets
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT07317440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07317440.